These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6187823)

  • 41. Host modification of Sindbis virus sialic acid content influences alternative complement pathway activation and virus clearance.
    Hirsch RL; Griffin DE; Winkelstein JA
    J Immunol; 1981 Nov; 127(5):1740-3. PubMed ID: 6117595
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immune effect of heat-killed multistrain of Lactobacillus acidophilus against Salmonella typhimurium invasion to mice.
    Lin WH; Yu B; Lin CK; Hwang WZ; Tsen HY
    J Appl Microbiol; 2007 Jan; 102(1):22-31. PubMed ID: 17184316
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genetic control of the innate resistance of mice to Salmonella typhimurium: expression of the Ity gene in peritoneal and splenic macrophages isolated in vitro.
    Lissner CR; Swanson RN; O'Brien AD
    J Immunol; 1983 Dec; 131(6):3006-13. PubMed ID: 6358358
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The full expression of the ity phenotype in ityr mice requires C3 activation by Salmonella lipopolysaccharide.
    Nishikawa F; Yoshikawa S; Harada H; Kita M; Kita E
    Immunology; 1998 Dec; 95(4):640-7. PubMed ID: 9893057
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A phagocytosis promoting factor of rat serum independent of the complement system.
    McLain S; Siegel J; Molnar J; Allen C; Sabet T
    J Reticuloendothel Soc; 1976 Mar; 19(3):127-38. PubMed ID: 1263186
    [No Abstract]   [Full Text] [Related]  

  • 46. Halogenation and proteolysis of complement component C3 on Salmonella typhimurium during phagocytosis by human neutrophils.
    Joiner KA; Schweinle JE
    J Immunol; 1989 May; 142(9):3164-70. PubMed ID: 2540237
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Salmonella, complement and mouse macrophages.
    Mäkelä PH; Hovi M; Saxén H; Valtonen M; Valtonen V
    Immunol Lett; 1988 Nov; 19(3):217-22. PubMed ID: 2466776
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Activation of the alternative complement pathway by Histoplasma capsulatum.
    Ratnoff WD; Pepple JM; Winkelstein JA
    Infect Immun; 1980 Oct; 30(1):147-9. PubMed ID: 7439970
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Complement activation by aluminium and zirconium compounds.
    Ramanathan VD; Badenoch-Jones P; Turk JL
    Immunology; 1979 Aug; 37(4):881-8. PubMed ID: 500133
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The general and local response to injury related to complement activation.
    Heideman M; Gelin LE
    Acta Chir Scand Suppl; 1979; 489():215-23. PubMed ID: 291258
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Activation of complement system by porins extracted from Salmonella typhimurium.
    Galdiero F; Tufano MA; Sommese L; Folgore A; Tedesco F
    Infect Immun; 1984 Nov; 46(2):559-63. PubMed ID: 6094352
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Opsonizing factors in rat serum. II. Serum component taking part in the phagocytosis of S. typhimurium.
    Slopek S; Grzybek-Hryncewicz K; Ladosz J; Kubis K
    Arch Immunol Ther Exp (Warsz); 1965; 13(3):312-7. PubMed ID: 5319927
    [No Abstract]   [Full Text] [Related]  

  • 53. Substances that can trigger activation of the alternative pathway of complement have anti-melanoma activity in mice.
    Cooper PD; Sim RB
    Int J Cancer; 1984 May; 33(5):683-7. PubMed ID: 6724743
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [A new C3NeF assay with zymosan-treated guinea-pig serum].
    Ohmori F; Ohi H; Seki M; Watanabe S; Hatano M
    Nihon Jinzo Gakkai Shi; 1986 Oct; 28(10):1423-7. PubMed ID: 3820819
    [No Abstract]   [Full Text] [Related]  

  • 55. Activation of the alternative complement pathway by L-phase variants of gram-positive bacteria.
    Saulsbury FT; Winkelstein JA
    Infect Immun; 1979 Mar; 23(3):711-6. PubMed ID: 457256
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunoregulation by macrophages: differential secretion of prostaglandin E and interleukin 1 during infection with Salmonella enteritidis.
    Cahill J; Hopper KE
    Cell Immunol; 1982 Mar; 67(2):229-40. PubMed ID: 6805961
    [No Abstract]   [Full Text] [Related]  

  • 57. Studies on the mechanism of PMN activation. II. By triggering the alternative pathway of complement activation.
    Müller J; Botzenhardt U; Lemmel EM
    Blut; 1982 Jul; 45(1):13-22. PubMed ID: 6177367
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The oxidative burst triggered by Salmonella typhimurium in differentiated U937 cells requires complement and a complete bacterial lipopolysaccharide.
    Château MT; Caravano R
    FEMS Immunol Med Microbiol; 1997 Jan; 17(1):57-66. PubMed ID: 9012444
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of zymosan-induced alternative complement pathway activation by concanavalin A.
    Smith MC; Pensky J; Naff GB
    Infect Immun; 1982 Dec; 38(3):1279-84. PubMed ID: 6924928
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Complement (C3)-activated phagocytosis by lung macrophages.
    Shurin SB; Stossel TP
    J Immunol; 1978 Apr; 120(4):1305-12. PubMed ID: 641349
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.